Novartis pays $346.7 million to resolve widespread FCPA offenses
Pharmaceutical giant Novartis AG and two subsidiaries (one current and one former) agreed Thursday to pay the DOJ and SEC $346.7 million in penalties and disgorgement to resolve FCPA offenses in Greece, Vietnam, and South Korea.… Continue Reading